Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Short term Debt (2016 - 2025)

Historic Short term Debt for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $586.0 million.

  • Eastman Chemical's Short term Debt rose 3022.22% to $586.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $586.0 million, marking a year-over-year increase of 3022.22%. This contributed to the annual value of $586.0 million for FY2025, which is 3022.22% up from last year.
  • Latest data reveals that Eastman Chemical reported Short term Debt of $586.0 million as of Q4 2025, which was up 3022.22% from $290.0 million recorded in Q3 2025.
  • In the past 5 years, Eastman Chemical's Short term Debt registered a high of $1.1 billion during Q4 2022, and its lowest value of $285.0 million during Q1 2025.
  • Its 5-year average for Short term Debt is $674.8 million, with a median of $668.5 million in 2023.
  • In the last 5 years, Eastman Chemical's Short term Debt tumbled by 6379.89% in 2021 and then surged by 20370.37% in 2022.
  • Eastman Chemical's Short term Debt (Quarter) stood at $747.0 million in 2021, then soared by 50.74% to $1.1 billion in 2022, then crashed by 51.95% to $541.0 million in 2023, then decreased by 16.82% to $450.0 million in 2024, then soared by 30.22% to $586.0 million in 2025.
  • Its Short term Debt stands at $586.0 million for Q4 2025, versus $290.0 million for Q3 2025 and $344.0 million for Q2 2025.